MECP2-Related Disorders in Males

Area of Science:

• Genetics
• Neurology
• Pediatrics

Background:

• Methyl CpG binding protein 2 (MECP2) is crucial for neurodevelopment, located on the X chromosome.
• Loss-of-function mutations in MECP2 cause Rett syndrome (RTT), primarily affecting females.
• MECP2 gene alterations in males present a broad clinical spectrum, complicating diagnosis.

Purpose of the Study:

• To review MECP2 variants and alterations in males.
• To explore genotype-phenotype correlations in male MECP2 disorders.
• To differentiate MECP2-related conditions in males.

Main Methods:

• Literature review of MECP2 variants and associated phenotypes in males.
• Analysis of clinical presentations in Rett syndrome and MECP2 duplication syndrome.
• Examination of inheritance patterns and diagnostic challenges.

Main Results:

• MECP2 mutations in males lead to varied neurological conditions, unlike typical RTT in females.
• MECP2 duplication syndrome predominantly affects males, often with maternal inheritance.
• Variants of unknown significance in MECP2 pose diagnostic challenges in males.

Conclusions:

• Male MECP2 disorders encompass a range of phenotypes, distinct from classical RTT.
• Understanding MECP2 variants is critical for accurate diagnosis and management in males.
• Further research is needed to fully elucidate MECP2 genotype-phenotype correlations in males.